EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Coagulation factor II receptor-like 1 as a prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma

Yong Gang Dai, Shiliang Cheng, Wei Wang, Hongya Wang, Lu Zhang, Xuewei Zhuang

PeerJ · 18.03.2026 · 14 · e20970

DOI: 10.7717/peerj.20970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 18.03.2026. Verfasst von Yong Gang Dai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan City, Shandong Province, China. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Biomarkers, Tumor, Head and Neck Neoplasms. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Society of Geriatrics 2021 Science, Technology Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck squamous cell carcinoma (HNSCC) remains a major cause of cancer mortality, and robust biomarkers are needed for prognosis stratification and immuno-oncology research. We investigated coagulation factor II receptor-like 1 (F2RL1) in HNSCC, focusing on expression, clinical outcomes and immune associations.

Methods

RNA sequencing and clinical follow-up data from The Cancer Genome Atlas head and neck squamous cell carcinoma cohort (TCGA-HNSC) were analysed. Three independent Gene Expression Omnibus (GEO) cohorts (GSE9844, GSE55547 and GSE55548) were used for external confirmation, with preprocessing and differential-expression exports generated using Xiantao Academic. Immune infiltration, functional enrichment and multi-omics annotations were assessed. Experimental validation was performed using reverse transcription quantitative polymerase chain reaction (RT-qPCR), western blotting and immunohistochemistry (IHC).

Results

F2RL1 was significantly upregulated in HNSCC and was associated with worse overall survival (OS). Expression differences were consistent across the three GEO cohorts. F2RL1 showed significant associations with immune cell infiltration and immune checkpoint genes, and correlated with DNA methylation features and N6-methyladenosine (m6A) regulators. A nomogram was constructed to estimate 1-, 3- and 5-year OS.

Conclusion

F2RL1 is reproducibly overexpressed in HNSCC and is linked to adverse outcomes and immune-related features, supporting its potential as a prognostic biomarker and candidate therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckBiomarkers, TumorHead and Neck NeoplasmsHumansPrognosisGene Expression Regulation, NeoplasticFemaleMaleUp-Regulation

Stichwörter der Autor:innen

F2RL1Head and neck squamous cell carcinomaImmune infiltrationN6-methyladenosinePrognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan City, Shandong Province, China.
  • Department of Clinical Microbiology Laboratory, Shandong Second Provincial General Hospital, Jinan City, Shandong Province, China.

Förderung

  • Shandong Society of Geriatrics 2021 Science
  • Technology Development Plan

Zitieren

APA

Dai, Y. G., Cheng, S., Wang, W., Wang, H., Zhang, L., & Zhuang, X. (2026). Coagulation factor II receptor-like 1 as a prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma. PeerJ, 14, e20970. https://doi.org/10.7717/peerj.20970

Vancouver

Dai YG, Cheng S, Wang W, Wang H, Zhang L, Zhuang X. Coagulation factor II receptor-like 1 as a prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma. PeerJ. 2026;14:e20970. doi:10.7717/peerj.20970

BibTeX
@article{Dai2026,
  author = {Dai, Yong Gang and Cheng, Shiliang and Wang, Wei and Wang, Hongya and Zhang, Lu and Zhuang, Xuewei},
  title = {Coagulation factor II receptor-like 1 as a prognostic and immuno-modulatory factor in head and neck squamous cell carcinoma},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e20970},
  doi = {10.7717/peerj.20970}
}
Kostenlos starten →